FIELD OF THE INVENTION
This invention relates to the field of protein tyrosine phosphatase inhibition.
BACKGROUND OF THE INVENTION
This invention relates to a novel class of phosphonic acid derivatives that are inhibitors of PTP-1B.
Reversible protein tyrosine phosphorylation, coordinated by the
FIELD OF THE INVENTION
This invention relates to the field of protein tyrosine phosphatase inhibition.
BACKGROUND OF THE INVENTION
This invention relates to a novel class of phosphonic acid derivatives that are inhibitors of PTP-1B.
Reversible protein tyrosine phosphorylation, coordinated by the
This application is the National Stage of Application No. PCT/EP2006/046543, filed on Dec. 6, 2006, which claims benefit under 35 U.S.C. .sctn.119(a-d) of U.S. Provisional Application No. 60/748,491, filed Dec. 8, 2005, the contents of which are incorporated herein by reference in their
FIELD OF THE INVENTION
The present invention is related to the use of oxindole hydrazide derivatives of formula (I) for the treatment and/or prevention of metabolic disorders mediated by insulin resistance or hyperglycemia, comprising diabetes type I and/or II, inadequate glucose tolerance, insulin
FIELD OF THE INVENTION
The present invention is related to substituted methylene amide derivatives of formula (I), in particular for the treatment and/or prevention of metabolic disorders mediated by insulin resistance or hyperglycemia, comprising diabetes type I and/or II, inadequate glucose
FIELD OF THE INVENTION
This invention relates generally to a weight control product that is administered enterally to mammals in need of losing weight and/or reducing the blood plasma lipid levels. The weight control product comprises a mixture of guggul extract and phosphate salts. The inventive
REFERENCE TO CORRESPONDING APPLICATIONS
The present application is the 371 national stage application based on International Application No. PCT/CN2015/097938, filed Dec. 18, 2015, which claims priority to Chinese Patent Application No. 20151057895.1, filed Sep. 11, 2015, Chinese Patent Application
TECHNICAL FIELD
The present invention relates to a novel azole compound, more particularly, the present invention relates to an azole compound or a pharmaceutically acceptable salt thereof having a protein tyrosine phosphatase 1B (PTP1B) inhibitory activity, and a pharmaceutical composition
TECHNICAL FIELD
This invention relates to a novel depsipeptide and a pharmaceutical preparation containing the same as an active ingredient. The depsipeptides of the invention have a promoting activity on the production of apolipoprotein E, and they are useful as a therapeutic agent for neurologic
The present invention relates to thiadiazolidinone derivatives, pharmaceutical compositions containing such compounds, methods of making such and methods of treating conditions mediated by protein tyrosine phosphatases by employing such compounds.
Accordingly, the present invention provides
The present invention relates to thiadiazolidinone derivatives, pharmaceutical compositions containing such compounds, methods of making such and methods of treating conditions mediated by protein tyrosine phosphatases by employing such compounds.
Accordingly, the present invention provides
Најкомплетнија база лековитог биља подржана науком
Ради на 55 језика
Биљни лекови потпомогнути науком
Препознавање биљака по слици
Интерактивна ГПС мапа - означите биље на локацији (ускоро)
Читајте научне публикације повезане са вашом претрагом
Претражите лековито биље по њиховим ефектима
Организујте своја интересовања и будите у току са истраживањем вести, клиничким испитивањима и патентима
Упишите симптом или болест и прочитајте о биљкама које би могле да помогну, укуцајте неку биљку и погледајте болести и симптоме против којих се користи. * Све информације се заснивају на објављеним научним истраживањима